Literature DB >> 20150913

c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.

X Li1, Q Ma, J Wang, X Liu, Y Yang, H Zhao, Y Wang, Y Jin, J Zeng, J Li, L Song, X Li1, P Li, X Qian, C Cao.   

Abstract

Galectin-3 (Gal3) has important roles in tumor transformation and metastasis. This study shows that c-Abl and Abl-related gene (Arg) associate with and phosphorylate Gal3. The SH (Src homology)3 domains of c-Abl/Arg bind to a P(80)GPPSGP motif of Gal3, and Tyr79 and Tyr118 are the major tyrosine phosphorylation sites. A consequence of this interaction and phosphorylation is the significant impairment of chaperone-mediated autophagy of Gal3. Cells expressing Gal3 and treated with the c-Abl/Arg inhibitor STI571, Gal3-depleted cells, and Gal3-depleted cells expressing Gal3 phosphorylation mutants all display an increased sensitivity to apoptosis-inducing agents. In addition, tumor cells expressing the phosphorylation mutants show impaired tumorigenicity. These results partially explain the antiapoptotic effect of Abl and Arg. As tumors frequently overexpress Gal3, a c-Abl/Arg-specific inhibitor may potentially be applied along with other antitumor drugs to target the lysosomal degradation of Gal3 in tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150913     DOI: 10.1038/cdd.2010.8

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  19 in total

1.  Role of c-Abl in L-selectin shedding from the neutrophil surface.

Authors:  Carissa J Ball; Michael R King
Journal:  Blood Cells Mol Dis       Date:  2011-02-01       Impact factor: 3.039

2.  Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.

Authors:  Tatiana Lobry; Roy Miller; Nathalie Nevo; Celine J Rocca; Jinzhong Zhang; Sergio D Catz; Fiona Moore; Lucie Thomas; Daniel Pouly; Anne Bailleux; Ida Chiara Guerrera; Marie-Claire Gubler; Wai W Cheung; Robert H Mak; Tristan Montier; Corinne Antignac; Stephanie Cherqui
Journal:  Kidney Int       Date:  2019-03-06       Impact factor: 10.612

3.  Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia.

Authors:  Mio Yamamoto-Sugitani; Junya Kuroda; Eishi Ashihara; Hisao Nagoshi; Tsutomu Kobayashi; Yosuke Matsumoto; Nana Sasaki; Yuji Shimura; Miki Kiyota; Ryuko Nakayama; Kenichi Akaji; Tomohiko Taki; Nobuhiko Uoshima; Yutaka Kobayashi; Shigeo Horiike; Taira Maekawa; Masafumi Taniwaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  Galectin-3 secretion and tyrosine phosphorylation is dependent on the calpain small subunit, Calpain 4.

Authors:  Shalini Menon; Choong-Min Kang; Karen A Beningo
Journal:  Biochem Biophys Res Commun       Date:  2011-05-27       Impact factor: 3.575

5.  Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.

Authors:  Vitaly Balan; Pratima Nangia-Makker; Dhong Hyo Kho; Yi Wang; Avraham Raz
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

6.  Galectin-3: A novel substrate for c-Abl kinase.

Authors:  Vitaly Balan; Pratima Nangia-Makker; Young Suk Jung; Yi Wang; Avraham Raz
Journal:  Biochim Biophys Acta       Date:  2010-06-30

7.  Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.

Authors:  Jian-Ying Zhou; Leila Afjehi-Sadat; Seneshaw Asress; Duc M Duong; Merit Cudkowicz; Jonathan D Glass; Junmin Peng
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

8.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

Review 9.  Glycobiology of cell death: when glycans and lectins govern cell fate.

Authors:  R G Lichtenstein; G A Rabinovich
Journal:  Cell Death Differ       Date:  2013-05-24       Impact factor: 15.828

Review 10.  Role of ABL family kinases in cancer: from leukaemia to solid tumours.

Authors:  Emileigh K Greuber; Pameeka Smith-Pearson; Jun Wang; Ann Marie Pendergast
Journal:  Nat Rev Cancer       Date:  2013-07-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.